CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
TOO is a microarray-based gene expression test that analyzes a tumor’s genomic information to help identify its origin. TOO assesses 2,000 individual genes, covering 15 of the most common tumor types (representing 58 morphologies) and 90 percent of all solid tumors. These tumors include thyroid, breast, non-small cell lung, pancreas, gastric, colorectal, liver, bladder, kidney, non-Hodgkin’s lymphoma, melanoma, ovarian, sarcoma, testicular germ cell, and prostate.
Cancer Genetics, 201-528-9200
Pages: 1 2